Hartford Business.com
September 06, 2010
Browse News by Topic
- Agriculture
- Architecture
- Banking & Finance
- Biotechnology
- Construction
- Economy
- Education
- Energy
- Government & Politics
- Health Care
- Insurance
- Legal
- Manufacturing
- Media & Marketing
- Nonprofits
- Real Estate
- Restaurant & Food
- Retail
- Small Business
- Technology
- Telecom
- Tourism
- Transportation
Data Products
To Do List
- Subscribe to the HBJ
- Signup for HBJ Today & eNews
- Get In The HBJ (PDF)
- View HBJ Business Profiles
- Get Your Company Listed in the HBJ
- View Book Of Lists Info
- Send Us A Press Release
- Add a Calendar Item
- Advertise in the HBJ
- Register for the CT Business Expo
- Update your account information
Awards & Events
- View Supplements Online
- Work Force Webinar
- Photo Gallery
- Health Care Heroes
- Diversity
- Best Places to Work
- eTechnology Summit and Strateg-e Awards
- Women in Business
- CT Business Expo
- Business Champions
- Nonprofit Heroes
- Small Business Awards
- Business Energy Summit
- 40 Under Forty
- CFO of the Year
- Lifetime Achievement
Search
Biotechnology News RSS
-
Pfizer buying Mass.’ FoldRx (posted 09/01/10 at 11:38am)
Drug giant Pfizer Inc., with research operations in Groton, said Wednesday it will buy privately held FoldRx Pharmaceuticals Inc. of Cambridge, Mass., for an undisclosed amount, expanding its pipeline of potential products.
-
Branford’s CAS Medical names new CEO (posted 08/31/10 at 11:27am)
CAS Medical Systems Inc. named veteran Connecticut biotech executive Thomas M. Patton as president and chief executive of the Branford medical devices maker.
-
Wallingford’s Z-Medica enters Japan market (posted 08/30/10 at 1:16pm)
Wallingford medical device maker Z-Medica Inc. has signed a deal with Japan's leading medical electronics maker to distribute exclusively Z-Medica's wound-dressing line in that Asian country.
-
Mass. firm’s cancer drug denied FDA OK (posted 08/27/10 at 8:16am)
Federal regulators have ruled that a potential breast cancer treatment from ImmunoGen, of Waltham, Mass., failed to meet the standard for accelerated approval, The Associated Press reports.
-
Pfizer shares slip on poor Sutent results (posted 08/24/10 at 11:24am)
Shares of Pfizer Inc. slipped in late morning trading Tuesday, a day after the drugmaker with research operations in Groton said a drug failed in a late-stage study of lung cancer patients, The Associated Press reports.
-
FDA OKs Alexion’s Rhode Island facility (posted 08/23/10 at 11:40am)
Cheshire drug maker Alexion Pharmaceuticals Inc. said Monday the Food and Drug Administration cleared the company's Rhode Island manufacturing facility for Soliris, The Associated Press reports.
-
New Haven’s Achillion posts 2Q loss (posted 08/13/10 at 11:22am)
Achillion Pharmaceuticals Inc. on Friday posted a second-quarter net loss but still has sufficient cash reserves to continue development of its small-molecule drug treatments for infectious blood-borne diseases.
-
GE takes wing on nanoresearch project (posted 08/12/10 at 11:42am)
A research team led by Fairfield-based General Electric Co. has won a $6.3 million defense contract to mimic the chemical-sensing properties of butterflies to devise nanosensors capable of sniffing out explosives and chemical agents, but whose commercial applications could some day identify air pollutants, tainted food, even human disease.
-
<< Previous | 2 | 3 | 4 of 18 Next >>